Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04530526 · ClinicalTrials.gov registry record · NA
Surgical Treatment of Post-surgical Mastectomy Pain Utilizing the Regenerative Peripheral Nerve Interface
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04530526 is a NA study that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 26 participants.
The verdict
NCT04530526, a NA study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Post-mastectomy pain due to nerve injury leads to long-term opioid use and diminished quality-of-life. The investigators on this study will evaluate the regenerative peripheral nerve interface (RPNI), a novel surgical approach to neuroma treatment, to improve patient-reported post-mastectomy pain and definitively treat intercostal neuromas after mastectomy.
Interventions
- PROCEDURE Regenerative Peripheral Nerve Interface
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-07-12 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04530526
The ClinicalTrials.gov registry entry for NCT04530526 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Regenerative Peripheral Nerve Interface is the first listed.
NCT04530526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04530526 about?
NCT04530526 is a clinical study titled "Surgical Treatment of Post-surgical Mastectomy Pain Utilizing the Regenerative Peripheral Nerve Interface". Post-mastectomy pain due to nerve injury leads to long-term opioid use and diminished quality-of-life. The investigators on this study will evaluate the regenerative peripheral nerve interface (RPNI), a novel surgical approach to neuroma treatment, to improve patient-reported post-mastectomy pain an...
What is the current status of trial NCT04530526?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2019-07-12. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT04530526?
The interventions under investigation include: Regenerative Peripheral Nerve Interface (PROCEDURE).
Who is sponsoring clinical trial NCT04530526?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.